246 related articles for article (PubMed ID: 22115703)
41. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
[TBL] [Abstract][Full Text] [Related]
42. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women.
Daghestani MH
Int J Gynaecol Obstet; 2018 Aug; 142(2):162-169. PubMed ID: 29745981
[TBL] [Abstract][Full Text] [Related]
44. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
Güneş M; Bukan N
Gynecol Endocrinol; 2015; 31(11):903-6. PubMed ID: 26291814
[TBL] [Abstract][Full Text] [Related]
45. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
Chou KH; von Eye Corleta H; Capp E; Spritzer PM
Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
[TBL] [Abstract][Full Text] [Related]
46. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
[TBL] [Abstract][Full Text] [Related]
47. Gonadotropin levels in women with polycystic ovary syndrome: their relationship to body weight and insulin levels.
Tropeano G; Vuolo IP; Lucisano A; Liberale L; Barini A; Carfagna P; Caroli G; Menini E; dell'Acqua S
J Endocrinol Invest; 1996 Mar; 19(3):139-45. PubMed ID: 8743278
[TBL] [Abstract][Full Text] [Related]
48. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome.
Grulet H; Hecart AC; Delemer B; Gross A; Sulmont V; Leutenegger M; Caron J
Clin Endocrinol (Oxf); 1993 Jun; 38(6):621-6. PubMed ID: 8334748
[TBL] [Abstract][Full Text] [Related]
49. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.
Dale PO; Tanbo T; Vaaler S; Abyholm T
Fertil Steril; 1992 Sep; 58(3):487-91. PubMed ID: 1521640
[TBL] [Abstract][Full Text] [Related]
50. [Association of monocyte chemoattractant protein-1 and the clinical characteristics of polycystic ovary syndrome: analysis of 65 cases].
Hu WH; Qiao J; Li MZ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(11):721-4. PubMed ID: 17565837
[TBL] [Abstract][Full Text] [Related]
51. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
[TBL] [Abstract][Full Text] [Related]
52. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
[TBL] [Abstract][Full Text] [Related]
53. Plasma selenium levels in Turkish women with polycystic ovary syndrome.
Coskun A; Arikan T; Kilinc M; Arikan DC; Ekerbiçer HÇ
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):183-6. PubMed ID: 23490536
[TBL] [Abstract][Full Text] [Related]
54. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
Zueff LF; Martins WP; Vieira CS; Ferriani RA
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
[TBL] [Abstract][Full Text] [Related]
55. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
56. Body mass index and gonadotropin hormones (LH & FSH) associate with clinical symptoms among women with polycystic ovary syndrome.
Esmaeilzadeh S; Andarieh MG; Ghadimi R; Delavar MA
Glob J Health Sci; 2014 Sep; 7(2):101-6. PubMed ID: 25716399
[TBL] [Abstract][Full Text] [Related]
57. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
58. Ultrasonography of the ovaries and its correlation with clinical and endocrine parameters in infertile women with PCOS.
Sikka P; Gainder S; Dhaliwal LK; Bagga R; Sialy R; Sahdev S
Int J Fertil Womens Med; 2007; 52(1):41-7. PubMed ID: 17987887
[TBL] [Abstract][Full Text] [Related]
59. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
[TBL] [Abstract][Full Text] [Related]
60. Daytime decrease of prolactin levels is associated with PCOS regardless to nutritional status and other hormones levels.
Franik G; Madej P; Guz-Lem M; Owczarek A; Chudek J; Olszanecka-Glinianowicz M
Gynecol Endocrinol; 2017 May; 33(5):336-341. PubMed ID: 28277129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
